New Bristol, Pfizer clot drug saves lives in study
PARIS (Reuters) - An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market
Ben Hirschler
PARIS
Sun Aug 28, 2011 10:35am EDT
link-
http://www.reuters.com/article/2011/08/28/us-heart-bristol-pfizer-idUSTRE77R0LF20110828